http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013542210-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013542210-A |
| titleOfInvention | Quinazoline complex and method for preparing quinazoline complex |
| abstract | Kind Code: A1 Quinazoline derivatives and quinazoline complexes that have molecular targeting properties and can act as tyrosine protein kinase inhibitors, and methods for their preparation are provided. The present invention provides a quinazoline derivative represented by the general formula (1), a quinazoline complex as a protein kinase inhibitor, and a method for preparing them. In this case, at least one of R and R ′ in the general formula (1) is a group containing an atom capable of coordinating with a noble metal, and m and n are the same or different and are an integer of 0 to 5 It is. The quinazoline complex as a protein kinase inhibitor is composed of a coordination compound containing a noble metal and the quinazoline derivative ligand capable of coordinating with the noble metal in the coordination compound. [Chemical 1] [Selection] Figure 1 |
| priorityDate | 2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.